
### [MONDO:0000463](http://purl.obolibrary.org/obo/MONDO_0000463)
**Label:** urofacial syndrome

**Subclasses:** [MONDO:0014049](http://purl.obolibrary.org/obo/MONDO_0014049) (urofacial syndrome 2), [MONDO:0009368](http://purl.obolibrary.org/obo/MONDO_0009368) (Urofacial Syndrome type 1), 

**Mapped go classes:** [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0043395](http://purl.obolibrary.org/obo/GO_0043395) (heparan sulfate proteoglycan binding), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030198](http://purl.obolibrary.org/obo/GO_0030198) (extracellular matrix organization), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0005578](http://purl.obolibrary.org/obo/GO_0005578) (proteinaceous extracellular matrix), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0016798](http://purl.obolibrary.org/obo/GO_0016798) (hydrolase activity, acting on glycosyl bonds), 

**Class expressions from DL-Learner:**

- [GO:0043395](http://purl.obolibrary.org/obo/GO_0043395) (heparan sulfate proteoglycan binding) 75.00%
- [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular) 75.00%
- [GO:0043394](http://purl.obolibrary.org/obo/GO_0043394) (proteoglycan binding) and [GO:1901681](http://purl.obolibrary.org/obo/GO_1901681) (sulfur compound binding) 60.36%
- [GO:0043168](http://purl.obolibrary.org/obo/GO_0043168) (anion binding) and [GO:0043394](http://purl.obolibrary.org/obo/GO_0043394) (proteoglycan binding) 60.36%
- [GO:0043167](http://purl.obolibrary.org/obo/GO_0043167) (ion binding) and [GO:0043394](http://purl.obolibrary.org/obo/GO_0043394) (proteoglycan binding) 60.36%
- [GO:0043168](http://purl.obolibrary.org/obo/GO_0043168) (anion binding) and [GO:0043394](http://purl.obolibrary.org/obo/GO_0043394) (proteoglycan binding) and [GO:1901681](http://purl.obolibrary.org/obo/GO_1901681) (sulfur compound binding) 60.36%
- [GO:0043167](http://purl.obolibrary.org/obo/GO_0043167) (ion binding) and [GO:0043394](http://purl.obolibrary.org/obo/GO_0043394) (proteoglycan binding) and [GO:1901681](http://purl.obolibrary.org/obo/GO_1901681) (sulfur compound binding) 60.36%
- [GO:0043394](http://purl.obolibrary.org/obo/GO_0043394) (proteoglycan binding) 53.87%
- Thing 50.90%
- [GO:1901681](http://purl.obolibrary.org/obo/GO_1901681) (sulfur compound binding) 40.08%
- [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 33.98%
- [GO:0043167](http://purl.obolibrary.org/obo/GO_0043167) (ion binding) 30.30%
- [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding) 27.77%
- [GO:0005488](http://purl.obolibrary.org/obo/GO_0005488) (binding) 27.15%
- [GO:0044464](http://purl.obolibrary.org/obo/GO_0044464) (cell part) 26.99%


